Why the study?
Does tranexamic acid reduce composite bleeding outcomes in patients undergoing noncardiac surgery?
Population
Patients undergoing noncardiac surgery
Comparison
Tranexamic acid vs placebo
Authors
Loading...
Reduces bleeding in noncardiac surgery; cardiovascular noninferiority not established, leaving safety unresolved for further trials.
Does tranexamic acid reduce composite bleeding outcomes in patients undergoing noncardiac surgery?
In patients undergoing noncardiac surgery, tranexamic acid reduces bleeding but its cardiovascular safety (noninferiority) compared to placebo was not definitively established.
Devereaux et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: